thyroxine has been researched along with Chronic Hepatitis C in 17 studies
Thyroxine: The major hormone derived from the thyroid gland. Thyroxine is synthesized via the iodination of tyrosines (MONOIODOTYROSINE) and the coupling of iodotyrosines (DIIODOTYROSINE) in the THYROGLOBULIN. Thyroxine is released from thyroglobulin by proteolysis and secreted into the blood. Thyroxine is peripherally deiodinated to form TRIIODOTHYRONINE which exerts a broad spectrum of stimulatory effects on cell metabolism.
thyroxine : An iodothyronine compound having iodo substituents at the 3-, 3'-, 5- and 5'-positions.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Combined pegylated interferon and ribavirin therapy for chronic hepatitis C infection cause a wide range of side effects, including flu-like syndrome, hematological abnormalities, cardiovascular symptoms, gastrointestinal symptoms, pulmonary dysfunction, depression, and retinopathy." | 7.76 | [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C]. ( Jang, JY; Jeon, SR; Jeong, SW; Kim, BS; Kim, SK; Kim, YS; Lee, YN; Lim, JH; Roh, MO; Ryu, YS, 2010) |
| "Interferon (IFN) plus ribavirin therapy for chronic hepatitis C (CHC) virus infection has been associated with thyroid dysfunction." | 7.73 | Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis. ( Changchien, CS; Kee, KM; Lee, CM; Lu, SN; Tung, HD; Wang, JH; Wang, PW, 2006) |
| "Subclinical hypothyroidism is common in children with CHC receiving treatment with pegylated IFN-α-2b and RBV, but in most cases is transient." | 5.48 | Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin. ( Azzari, C; Cananzi, M; D'Antiga, L; Indolfi, G; Nebbia, G; Resti, M; Ricci, S; Serranti, D; Stagi, S, 2018) |
| "Combined pegylated interferon and ribavirin therapy for chronic hepatitis C infection cause a wide range of side effects, including flu-like syndrome, hematological abnormalities, cardiovascular symptoms, gastrointestinal symptoms, pulmonary dysfunction, depression, and retinopathy." | 3.76 | [Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C]. ( Jang, JY; Jeon, SR; Jeong, SW; Kim, BS; Kim, SK; Kim, YS; Lee, YN; Lim, JH; Roh, MO; Ryu, YS, 2010) |
| "Interferon (IFN) plus ribavirin therapy for chronic hepatitis C (CHC) virus infection has been associated with thyroid dysfunction." | 3.73 | Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis. ( Changchien, CS; Kee, KM; Lee, CM; Lu, SN; Tung, HD; Wang, JH; Wang, PW, 2006) |
| "Despite aggressive treatment of hepatic encephalopathy, there was no clinical improvement." | 2.41 | Primary hypothyroidism masquerading as hepatic encephalopathy: case report and review of the literature. ( Jones, MP; Pilger, P; Thobe, N, 2000) |
| "Subclinical hypothyroidism is common in children with CHC receiving treatment with pegylated IFN-α-2b and RBV, but in most cases is transient." | 1.48 | Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin. ( Azzari, C; Cananzi, M; D'Antiga, L; Indolfi, G; Nebbia, G; Resti, M; Ricci, S; Serranti, D; Stagi, S, 2018) |
| "An association between Graves' disease (GD) and chronic hepatitis C (C-HC) has been observed both in the presence and the absence of recombinant interferon-alpha (rIFN-alpha) treatment." | 1.33 | Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection. ( Barilli, AL; Bertoni, R; Coiro, V; Delsignore, R; Di Seclì, C; Ferrari, C; Finardi, L; Jotti, GS; La Gioia, D; Minelli, R; Valli, MA, 2005) |
| "116 patients with chronic hepatitis B or C were consecutively investigated." | 1.31 | Thyroid hypoechogenicity in patients with chronic hepatitis receiving interferon-alpha therapy: evaluation by standardized grey scale ultrasonography. ( Bogner, J; Gross, M; Schiemann, U; Schmidt, F; Walli, R, 2002) |
| "Each case of hyperthyroidism has to be precisely evaluated." | 1.30 | [Hepatitis C virus infection and thyroid diseases]. ( Bailly, F; Broussolle, C; Steineur, MP; Trépo, C; Zoulim, F, 1999) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 3 (17.65) | 18.2507 |
| 2000's | 9 (52.94) | 29.6817 |
| 2010's | 5 (29.41) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Serranti, D | 1 |
| Indolfi, G | 2 |
| Nebbia, G | 1 |
| Cananzi, M | 1 |
| D'Antiga, L | 1 |
| Ricci, S | 1 |
| Stagi, S | 2 |
| Azzari, C | 2 |
| Resti, M | 2 |
| Montes, ML | 1 |
| Fraile, JM | 1 |
| González, JJ | 1 |
| Arribas, JR | 1 |
| Moustafa, AH | 1 |
| Ali, EM | 1 |
| Mohamed, TM | 1 |
| Abdou, HI | 1 |
| Lee, YN | 1 |
| Jeong, SW | 1 |
| Lim, JH | 1 |
| Ryu, YS | 1 |
| Jeon, SR | 1 |
| Kim, SK | 1 |
| Jang, JY | 1 |
| Kim, YS | 1 |
| Kim, BS | 1 |
| Roh, MO | 1 |
| López, MM | 1 |
| Arráez Monllor, M | 1 |
| López Fernández, M | 1 |
| Hervas Abad, E | 1 |
| Hernández Alonso, E | 1 |
| Tran, HA | 1 |
| Ianna, EA | 1 |
| Jones, TL | 1 |
| Reeves, GE | 1 |
| Zantut-Wittmann, DE | 1 |
| Pavan, MH | 1 |
| Pavin, EJ | 1 |
| Goncales, FL | 1 |
| Schiemann, U | 1 |
| Walli, R | 1 |
| Schmidt, F | 1 |
| Bogner, J | 1 |
| Gross, M | 1 |
| Minelli, R | 3 |
| Valli, MA | 3 |
| Di Seclì, C | 2 |
| Finardi, L | 2 |
| Chiodera, P | 1 |
| Bertoni, R | 2 |
| Ferrari, C | 2 |
| Barilli, AL | 2 |
| Coiro, V | 2 |
| Saccani Jotti, G | 1 |
| Delsignore, R | 2 |
| La Gioia, D | 1 |
| Jotti, GS | 1 |
| Kee, KM | 1 |
| Lee, CM | 1 |
| Wang, JH | 1 |
| Tung, HD | 1 |
| Changchien, CS | 1 |
| Lu, SN | 1 |
| Wang, PW | 1 |
| Bartolini, E | 1 |
| Salti, R | 1 |
| de Martino, M | 1 |
| Kanda, K | 1 |
| Kayahara, T | 1 |
| Seno, H | 1 |
| Yamashita, Y | 1 |
| Chiba, T | 1 |
| Tsuboi, K | 1 |
| Katayama, M | 1 |
| Yuasa, R | 1 |
| Matoba, H | 1 |
| Nagayama, T | 1 |
| Ihara, F | 1 |
| Ooya, T | 1 |
| Matsuo, K | 1 |
| Otsuka, S | 1 |
| Miyachi, Y | 1 |
| Braverman, LE | 1 |
| Schianchi, C | 1 |
| Pedrazzoni, M | 1 |
| Fiaccadori, F | 1 |
| Salvi, M | 1 |
| Magotti, MG | 1 |
| Roti, E | 1 |
| Broussolle, C | 1 |
| Steineur, MP | 1 |
| Bailly, F | 1 |
| Zoulim, F | 1 |
| Trépo, C | 1 |
| Thobe, N | 1 |
| Pilger, P | 1 |
| Jones, MP | 1 |
1 review available for thyroxine and Chronic Hepatitis C
| Article | Year |
|---|---|
Primary hypothyroidism masquerading as hepatic encephalopathy: case report and review of the literature.
Topics: Aged; Diagnosis, Differential; Female; Hepatic Encephalopathy; Hepatitis C, Chronic; Humans; Hypothy | 2000 |
3 trials available for thyroxine and Chronic Hepatitis C
| Article | Year |
|---|---|
Is steroid therapy needed in the treatment of destructive thyrotoxicosis induced by alpha-interferon in chronic hepatitis C?
Topics: Adult; Anti-Inflammatory Agents; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Hypothyroid | 2005 |
Interferon-alpha-induced thyroid dysfunction in patients with chronic active hepatitis C: a transient, reversible and self-limited dysfunction.
Topics: Adult; Aged; Autoimmune Diseases; Female; Goiter; Hepatitis C, Chronic; Humans; Hypothyroidism; Inte | 1998 |
Recombinant interferon alpha (rIFN-alpha) does not potentiate the effect of iodine excess on the development of thyroid abnormalities in patients with HCV chronic active hepatitis.
Topics: Adult; Antibodies; Antiviral Agents; Female; Hepatitis C, Chronic; Humans; Interferon Type I; Iodide | 1999 |
13 other studies available for thyroxine and Chronic Hepatitis C
| Article | Year |
|---|---|
Transient Hypothyroidism and Autoimmune Thyroiditis in Children With Chronic Hepatitis C Treated With Pegylated-interferon-α-2b and Ribavirin.
Topics: Adolescent; Antiviral Agents; Autoantibodies; Case-Control Studies; Child; Child, Preschool; Female; | 2018 |
[Chorea during treatment with pegylated interferon and ribavirin in HIV-HCV coinfected patient].
Topics: Adult; Anti-HIV Agents; Antidepressive Agents; Antiviral Agents; Anxiety Disorders; Chorea; Citalopr | 2009 |
Oxidative stress and thyroid hormones in patients with liver diseases.
Topics: Adult; Alanine Transaminase; Antioxidants; Apolipoprotein A-I; Aspartate Aminotransferases; Biomarke | 2009 |
[Occurrence of diabetic ketoacidosis and autoimmune thyroiditis in a patient treated with pegylated interferon-alpha 2b and ribavirin for chronic hepatitis C].
Topics: Adult; Antiviral Agents; Diabetic Ketoacidosis; Drug Therapy, Combination; Female; Hepatitis C, Chro | 2010 |
[Acute hallucinatory psychosis secondary to oral glucocorticoid treatment in a patient diagnosed with Sheehan's syndrome].
Topics: Acute Disease; Female; Hallucinations; Hepatitis C, Chronic; Hormone Replacement Therapy; Humans; Hy | 2011 |
The adjuvant role of thyroxine in the treatment of chronic hepatitis C infection.
Topics: Antiviral Agents; Drug Therapy, Combination; Female; Hepatitis C, Chronic; Humans; Interferon-alpha; | 2012 |
Central hypothyroidism in patients with chronic hepatitis C and relation with interferon-alpha treatment.
Topics: Adult; Chi-Square Distribution; Female; Hepacivirus; Hepatitis C, Chronic; Humans; Hypothyroidism; I | 2011 |
Thyroid hypoechogenicity in patients with chronic hepatitis receiving interferon-alpha therapy: evaluation by standardized grey scale ultrasonography.
Topics: Adult; Antiviral Agents; Female; Hepatitis B, Chronic; Hepatitis C, Chronic; Humans; Hypothyroidism; | 2002 |
Graves' disease in interferon-alpha-treated and untreated patients with chronic hepatitis C virus infection.
Topics: Antiviral Agents; Autoantibodies; Female; Graves Disease; Hepacivirus; Hepatitis C, Chronic; Humans; | 2005 |
Thyroid dysfunction in patients with chronic hepatitis C receiving a combined therapy of interferon and ribavirin: incidence, associated factors and prognosis.
Topics: Antiviral Agents; Autoantibodies; Case-Control Studies; Female; Hepatitis C, Chronic; Humans; Interf | 2006 |
Thyroid function and anti-thyroid autoantibodies in untreated children with vertically acquired chronic hepatitis C virus infection.
Topics: Adolescent; Autoantibodies; Autoimmunity; Case-Control Studies; Child; Child, Preschool; Female; Hep | 2008 |
Conversion from latent to symptomatic Sheehan's syndrome by pegylated interferon therapy for chronic hepatitis C.
Topics: Adrenocorticotropic Hormone; Antiviral Agents; Female; Hepatitis C, Chronic; Hormones; Humans; Hypop | 2008 |
[Hepatitis C virus infection and thyroid diseases].
Topics: Adult; Antiviral Agents; Autoantibodies; Cross-Sectional Studies; Female; Hepatitis C; Hepatitis C, | 1999 |